Previous 10 | Next 10 |
SAN DIEGO, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Nanome , the first virtual reality software company to launch an immersive real-time collaboration platform for scientific discovery, today announced that the company has executed its largest deployment to date with Roivant Discovery ...
Gainers: Galera Therapeutics (NASDAQ:GRTX) +106%. Nuverra Environmental Solutions (NYSE:NES) +33%. CPS Technologies (NASDAQ:CPSH) +24%. Terminix (NYSE:TMX) +21%. Alzamend Neuro (NASDAQ:ALZN) +17%. MIND Technology (NASDAQ:MIND) +17%. Landec Corporation (NASDAQ:LNDC) +13%. Soliton (NASDAQ:SOLY)...
Palantir's Q3 showed solid growth continuing, with strengths in multiple key metrics supporting long-term growth targets, as well as new SPAC investments. Investments in these SPACs have reached $379.5 million, while current share values are ~$317 million, for a -19% return. Many ...
As scientists raced to uncover further details on the impact of the newly found Omicron variant on vaccine-driven immunity, COVID-19 antibody developers dominated best-performing healthcare stocks this week. While the sector became the fifth-worst performer in the S&P 500D dragged by the ...
The recent volatility on Wall Street continued during Wednesday's session, as fears about the Omicron variant continued to weigh on sentiment. Travel stocks felt the brunt of this concern, with United Airlines (NASDAQ:UAL), Delta Air Lines (NYSE:DAL), Carnival (NYSE:CCL), Alaska Air Group (NY...
Gainers: Arbutus Biopharma (NASDAQ:ABUS) +87%. MDJM (NASDAQ:MDJH) +41%. Context Therapeutics (NASDAQ:CNTX) +35%. Build-A-Bear Workshop (NYSE:BBW) +33%. Ardelyx (NASDAQ:ARDX) +28%. Ambarella (NASDAQ:AMBA) +25%. Roivant Sciences (NASDAQ:ROIV) +22%. Stran & Company (NASDAQ:STRN) +20%. Marpai...
Roivant Sciences Ltd. (ROIV) Q2 2021 Earnings Conference Call November15, 2021, 08:00 AM ET Company Participants Paul Davis – Head of Communications Matthew Gline – Chief Executive Officer Richard Pulik – Chief Financial Officer Frank Torti – Vant Chair Eric Venker...
The following slide deck was published by Roivant Sciences Ltd. in conjunction with their 2021 Q2 earnings call. For further details see: Roivant Sciences Ltd. 2021 Q2 - Results - Earnings Call Presentation
Roivant Sciences (NASDAQ:ROIV): FQ2 GAAP EPS of -$0.32 beats by $0.15. Revenue of $13.98M (+959.1% Y/Y) beats by $8.76M. Press Release For further details see: Roivant Sciences EPS beats by $0.15, beats on revenue
Roivant began trading on Nasdaq under “ROIV”; cash balance increased to $2.5 billion. Dermavant announced final results from the Phase 3 PSOARING 3 long-term extension study of tapinarof in patients with plaque psoriasis (n=763). The study demonstrated 58% of patie...
News, Short Squeeze, Breakout and More Instantly...
Roivant Sciences Ltd. Company Name:
ROIV Stock Symbol:
NASDAQ Market:
Roivant Sciences Ltd. Website:
2024-07-11 10:45:04 ET Rivian Automotive Inc (RIVN) RIVN is trading UP for the last 5 days, and it at trading at $16.74 with volume of 18,885,597 and a one day change of $0.37 (2.23%). Rivian Automotive Inc has a 52-week low of 12.15 and a 52-week high of $32.60. The business's 50-d...
2024-06-02 17:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BASEL, Switzerland and LONDON and NEW YORK, May 30, 2024 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported its financial results for the fourth quarter and fiscal year ended March 31, 2024, and provided a business update. Once-daily brepocitinib produced the best Treatment Failure...